重庆至信实业股份有限公司 2026 年第一次临时股东会会议资料 会议资料目录 | 2026 | 年第一次临时股东会会议须知 - | 3 | - | | --- | --- | --- | --- | | 2026 | 年第一次临时股东会会议议程 - | 5 | - | | | 议案一：关于变更公司注册资本、类型、住所暨修订《公司章程》的议案...- | 7 | - | | | 议案二：关于拟对外投资建设汽车冲焊零部件项目的议案 - | 9 | - | - 2 - 证券代码：603352 证券简称：至信股份 重庆至信实业股份有限公司 2026 年第一次临时股东会 会 议 资 料 二〇二六年三月 重庆至信实业股份有限公司 2026 年第一次临时股东会会议资料 重庆至信实业股份有限公司 2026 年第一次临时股东会 一、本次股东会设立会务组，具体负责会议期间的组织及相关会务工作。 二、为保证本次股东会的严肃性和正常秩序，切实维护股东的合法权益，务 请出席股东会的股东或股东代理人（以下统称"股东"）及相关人员准时到达会 场签到确认参会资格。股东参会登记当天没有通过邮件方式登记的，不在签到表 上登记签到。会议开始后，会 ...

Group 1 - The core viewpoint of the news is that Zhixin Co., Ltd. experienced a decline in stock price and trading volume on February 10, with a net financing outflow [1] - On February 10, Zhixin Co., Ltd. had a financing buy amount of 13.43 million yuan and a financing repayment of 17.14 million yuan, resulting in a net financing buy of -3.71 million yuan [1] - As of February 10, the total balance of margin trading for Zhixin Co., Ltd. was 111 million yuan, which accounts for 5.63% of its circulating market value [1] Group 2 - As of January 15, the number of shareholders for Zhixin Co., Ltd. reached 79,700, an increase of 612,953.85% compared to the previous period [2] - For the period from January to September 2025, Zhixin Co., Ltd. achieved an operating income of 2.697 billion yuan, representing a year-on-year growth of 28.52% [2] - The net profit attributable to the parent company for the same period was 165 million yuan, showing a year-on-year increase of 21.43% [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603352 证券简称：至信股份 公告编号：2026-007 重庆至信实业股份有限公司 关于召开2026年第一次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 股东会召开日期：2026年3月4日 (一)股东会类型和届次 2026年第一次临时股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2026年3月4日 14点 00分 召开地点：重庆市两江新区鱼嘴镇长惠路29号公司会议室 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2026年3月4日 至2026年3月4日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股东会召开当日的交易时间 段，即9:15-9:25，9:30-11:30，13:00-15:00；通过互联网投票平台的投票时间为 ...

Core Viewpoint - The company plans to invest up to 1.1 billion yuan in its wholly-owned subsidiary, Jinhua Zhixin Technology Co., Ltd., to expand production capacity and upgrade its industry in the automotive lightweight welding components and seat frame sectors [1] Group 1: Investment Details - The total investment amount for the automotive welding component project is not to exceed 1.1 billion yuan [1] - The project will be implemented by Jinhua Zhixin as the main project entity [1] Group 2: Market Focus - The project primarily targets the new energy vehicle market, specifically clients like Leap Motor [1] - The investment aims to support the company's business development in large lightweight automotive components and seat frames [1]

Core Viewpoint - The company intends to invest in its wholly-owned subsidiary, Jinhua Zhixin Technology Co., Ltd., to support clients like Leap Motor in the East China region through a project focused on automotive lightweight welding components and seat frames, with a total investment not exceeding 1.1 billion yuan [1] Group 1 - The project aims to expand production capacity and upgrade the industry related to automotive lightweight welding components and seat frames [1] - The investment will primarily target the new energy vehicle market, specifically serving clients such as Leap Motor [1] - The project will involve the construction of manufacturing and quality testing facilities to support business development in the large lightweight automotive components and seat frame sectors [1]

Group 1 - ZTE Corporation plans to invest 200 million RMB to subscribe to the Guangdong-Hong Kong-Macao Greater Bay Area Venture Capital Guidance Fund, focusing on areas supported by national policies such as new generation information technology and biotechnology [1] - Huayi Jewelry's subsidiary has reported overdue loans totaling 200 million RMB due to tight liquidity, with a cumulative overdue principal of 254 million RMB [2] - Guangzhou Baiyunshan Pharmaceutical's subsidiary has received approval for the consistency evaluation of Alfacalcidol soft capsules, which are used to treat calcium metabolism disorders [3] Group 2 - Kunming Pharmaceutical Group reported a 21.72% decline in revenue to 6.577 billion RMB and a 46% drop in net profit to 350 million RMB for 2025 [4] - Jiantou Energy's application for a specific stock issuance has been approved by the Shenzhen Stock Exchange [5] - Jinchuan Titanium Industry's subsidiary has temporarily suspended its sulfuric acid production due to reduced demand [6] Group 3 - Kelun Pharmaceutical's subsidiary has received approval for a new indication for its antibody-drug conjugate, which is used to treat advanced hormone receptor-positive breast cancer [7] - Fawer Co., Ltd. has completed the relocation of its Chongqing Yuantai Shock Absorber Company and commenced production [8] - Jiuzhoutong's subsidiary has received acceptance for the listing application of Betahistine Hydrochloride tablets [9] Group 4 - Zhongguancun plans to build a traditional Chinese medicine and raw material drug production base in Jiamusi City, Heilongjiang Province [11] - China Wuyi announced that part of its land in Kenya has been requisitioned by the government, with compensation of approximately 6.25 million RMB [12] - Times Electric reported a 15.46% increase in revenue to 28.761 billion RMB and a 10.88% increase in net profit to 4.105 billion RMB for 2025 [13] Group 5 - Top Cloud Agriculture's shareholder has received regulatory measures from the Zhejiang Securities Regulatory Bureau for failing to timely disclose shareholding changes [14] - Xinwanda's subsidiary has reached a settlement in a lawsuit involving over 2.314 billion RMB, with an estimated impact of 500 to 800 million RMB on net profit for 2025 [15] - Dongrui Co., Ltd. reported a 25.19% increase in pig sales revenue in January, totaling 214 million RMB [16] Group 6 - Tianjin Tianshi reported a 3.08% decline in revenue to 8.236 billion RMB, while net profit increased by 15.68% to 1.105 billion RMB for 2025 [17] - Wantong Expressway plans to invest approximately 5.42 billion RMB in the renovation and expansion of the Lianhuo Expressway [18] - Qiaoyin Co., Ltd. has pre-qualified for a sanitation integration service project worth approximately 73.8 million RMB [20] Group 7 - Jindi Co., Ltd. plans to acquire 100% equity of Yuni Precision for 116 million RMB, focusing on precision stamping products [21] - Heng Rui Medicine's HRS-4642 injection has been included in the list of breakthrough therapeutic varieties [22] - Tongde Chemical has had some assets frozen due to a financing lease dispute [23] Group 8 - Zhongli Co., Ltd. is establishing an industrial fund with a total commitment of approximately 408.76 million RMB, focusing on new materials and artificial intelligence [24] - Tianbang Food reported a 9.93% increase in pig sales revenue in January, totaling 674 million RMB [25] - New Hope reported a 10.03% decrease in pig sales revenue in January, totaling 1.628 billion RMB [26] Group 9 - Tainkang's subsidiary has received a drug registration certificate for Minoxidil topical solution [27] - Lihua Co., Ltd. reported a 9.8% increase in chicken sales revenue in January, totaling 1.289 billion RMB [28] - Guojitong General reported a 45.71% increase in net profit to 58.52 million RMB for 2025 [29] Group 10 - Zhixin Co., Ltd. plans to invest up to 1.1 billion RMB in an automotive stamping and welding parts project [30] - Chuangyuan Technology's subsidiary has pre-qualified for a National Grid project worth approximately 94.77 million RMB [31] - Lisheng Pharmaceutical's adenine phosphate raw material has passed the listing application [32] Group 11 - Tongguang Cable's subsidiary has pre-qualified for a National Grid project worth approximately 108 million RMB [33] - Zhenghong Technology reported a 7.74% increase in pig sales revenue in January, totaling 14.35 million RMB [34] - Pengding Holdings reported a 0.07% decrease in consolidated revenue in January, totaling 2.701 billion RMB [35] Group 12 - Hongri Pharmaceutical has received approval for clinical trials of its injectable drug for acute pancreatitis [36][37] - Xinhua Medical has decided to terminate the acquisition of a 36.19% stake in Wuhan Zhongzhi Biotechnology [38] - Tianyu Bio reported an 11.23% decrease in pig sales revenue in January, totaling 54.29 million RMB [39]

格隆汇2月6日丨至信股份(603352.SH)公布，根据公司战略发展及业务拓展需要，为进一步扩大公司生 产能力，就近配套华东区域及周边地区的零跑汽车等客户，提升客户服务水平和效率，公司拟对金华至 信进行增资（增资后金华至信注册资本不超过1亿元，以市场监管局实际登记为准），并由金华至信作 为项目实施主体，投资建设"汽车冲焊零部件项目"（具体以在有关部门最终备案名称为准）。公司或金 华至信拟与金华市婺城区人民政府签署投资协议、土地协议等相关协议。本项目总投资不超过11亿元 （其中包括土地、厂房、设备、设施、工装等），拟规划用地约100亩，地块拟位于浙江省金华市婺城 区金龙路与郑阳路交叉路口。 ...

重庆至信实业股份有限公司 章 程 二〇二六年二月 | | | | | | 重庆至信实业股份有限公司 章 程 第一章 总则 第一条 为维护重庆至信实业股份有限公司（以下简称"公司"）、股东、职 工和债权人的合法权益，规范公司的组织和行为，根据《中华人民共和国公司法》 （以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"） 和其他有关规定，制订本《重庆至信实业股份有限公司章程》（以下简称"本章 程"）。 第二条 公司系依照《公司法》和其他有关规定成立的股份有限公司。公司 是由重庆至信实业集团有限公司整体变更设立的股份有限公司。 公司采取发起设立的方式设立；公司在重庆两江新区市场监督管理局注册登 记，取得营业执照，营业执照号码：9150000050430952XP。 第三条 公司于 2025 年 11 月 26 日经中国证券监督管理委员会注册，首次向 社会公众发行人民币普通股 56,666,667 股，于 2026 年 1 月 15 日在上海证券交易 所上市。 第四条 公司注册名称：重庆至信实业股份有限公司。英文全称：Chongqing Zhixin Industrial Co., Ltd. ...

证券代码：603352 证券简称：至信股份 公告编号：2026-005 二、变更公司住所的相关情况 因行政区划调整，公司拟将住所由"重庆市江北区鱼嘴镇长惠路29号"变 更为"重庆市两江新区鱼嘴镇长惠路29号"，具体以相关审批部门登记结果为 准。 三、修订《公司章程》的具体情况 根据《中华人民共和国公司法》《上市公司章程指引（2025年修订）》的 有关规定，结合上述总股本、注册资本、公司类型及住所的变更情况，现拟对 《重庆至信实业股份有限公司章程（草案）》相关内容进行修订，并将名称变 更为《重庆至信实业股份有限公司章程》（以下简称"《公司章程》"），具 体修订内容如下： 重庆至信实业股份有限公司 关于变更公司注册资本、类型、住所 暨修订《公司章程》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重庆至信实业股份有限公司（以下简称"公司"或"至信股份"）于 2026 年 2 月 6 日召开第一届董事会第十七次会议，审议通过了《关于变更公司注册 资本、类型、住所暨修订<公司章程>的议案》，该事项尚需提交公司 2026 年第 ...

证券代码：603352 证券简称：至信股份 公告编号：2026-006 相关风险提示： 1、行业风险：本项目是基于公司战略发展的需要及对轻量化零部件和汽车 座椅骨架在新能源汽车行业发展的判断而投资，但新能源汽车的发展趋 势、市场变化，以及原材料价格波动等外部因素和公司内部管理、工艺 技术等均存在一定的不确定性，可能对本项目的建设运营和预期效益产 生不确定影响。 2、审批备案风险：本项目的实施尚需进行土地招拍挂、项目备案、建设规 划许可、环境影响评价等前置审批程序，如遇国家或地方有关政策调整、 项目审批等实施程序条件发生变化等情形，本项目实施可能存在变更、 延期、中止或终止的风险。 3、资金筹措风险：本项目资金需求较大，主要资金来源为自有资金或其他 自筹资金，如公司整体经营性现金流情况或融资条件不达市场预期，将 可能导致公司无法按时足额投入项目建设所需资金。 4、建设实施风险：本项目建设期 36 个月，项目建设及实施过程中，若遇 行业政策调整、市场环境变化、客户需求变动或施工管理等问题，可能 导致项目延期、变更或无法全部完成。 5、市场及盈利风险：对本项目的投资是公司基于当前市场前景和客户需求 所作的规划。尽管 ...